Literature DB >> 35794468

Identification of RPGR ORF15 mutation for X-linked retinitis pigmentosa in a large Chinese family and in vitro correction with prime editor.

Xiujuan Lv1, Zheng Zheng1, Xiao Zhi1, Yilin Zhou2, Jineng Lv1, Yue Zhou1, Binrong Wu1, Sixiu Liu1, Wei Shi3, Zongming Song4, Jinling Xu1, Jia Qu1, Dan Xu5, Feng Gu6.   

Abstract

X-linked retinitis pigmentosa (XLRP) is the most severe form of Retinitis Pigmentosa (RP) and one of the leading causes of blindness in the world. Currently, there is no effective treatment for RP. In the present study, we recruited a XLRP family and identified a 4 bp deletion mutation (c. 2234_2237del) in RPGR ORF15 with Sanger sequencing, which was located in the exact same region as the missing XES (X chromosome exome sequencing) coverage. Then, we generated cell lines harboring the identified mutation and corrected it via enhanced prime editing system (ePE). Collectively, Sanger sequencing identified a pathogenic mutation in RPGR ORF15 for XLRP which was corrected with ePE. This study provides a valuable insight for genetic counseling of the afflicted family members and prenatal diagnosis, also paves a way for applying prime editing based gene therapy in those patients.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Year:  2022        PMID: 35794468     DOI: 10.1038/s41434-022-00352-3

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  4 in total

Review 1.  Retinal dystrophies, genomic applications in diagnosis and prospects for therapy.

Authors:  Benjamin M Nash; Dale C Wright; John R Grigg; Bruce Bennetts; Robyn V Jamieson
Journal:  Transl Pediatr       Date:  2015-04

2.  Genotyping microarray: mutation screening in Spanish families with autosomal dominant retinitis pigmentosa.

Authors:  Fiona Blanco-Kelly; María García-Hoyos; Marta Cortón; Almudena Avila-Fernández; Rosa Riveiro-Álvarez; Ascensión Giménez; Inma Hernan; Miguel Carballo; Carmen Ayuso
Journal:  Mol Vis       Date:  2012-06-05       Impact factor: 2.367

3.  Microarray-based mutation detection and phenotypic characterization in Korean patients with retinitis pigmentosa.

Authors:  Cinoo Kim; Kwang Joong Kim; Jeong Bok; Eun-Ju Lee; Dong-Joon Kim; Ji Hee Oh; Sung Pyo Park; Joo Young Shin; Jong-Young Lee; Hyeong Gon Yu
Journal:  Mol Vis       Date:  2012-09-25       Impact factor: 2.367

4.  Clinical and Genetic Characteristics of Chinese Patients with Occult Macular Dystrophy.

Authors:  Dan-Dan Wang; Feng-Juan Gao; Jian-Kang Li; Fang Chen; Fang-Yuan Hu; Ge-Zhi Xu; Jian-Guo Zhang; Hao-Xiang Sun; Sheng-Hai Zhang; Ping Xu; Guo-Hong Tian; Ji-Hong Wu
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-03-09       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.